1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hives in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (22.22) | 18.7374 |
1990's | 8 (29.63) | 18.2507 |
2000's | 3 (11.11) | 29.6817 |
2010's | 8 (29.63) | 24.3611 |
2020's | 2 (7.41) | 2.80 |
Authors | Studies |
---|---|
Gomułka, K; Mędrala, W | 1 |
Cha, HY; Choi, BY; Jo, J; Jung, HW; Kang, HC; Park, HS; Shin, MK; Yang, EM; Ye, YM | 1 |
Calogiuri, GF; Delle Donne, P; Di Leo, E; Ferrannini, A; Nettis, E; Vacca, A | 1 |
Canonica, GW; Compalati, E | 1 |
Badyal, DK; Johnson, M; Kwatra, G; Thomas, EA | 1 |
Bartuzi, Z; Pałgan, K | 1 |
Bachert, C; González-Núñez, V; Mullol, J | 1 |
Cassano, N; Delle Donne, P; Di Leo, E; Foti, C; Nettis, E; Vacca, A; Vena, GA | 1 |
Ferrán, M; Giménez-Arnau, A; Izquierdo, I; Maurer, M; Metz, M; Scholz, E | 1 |
Maurer, M; Metz, M | 1 |
Abajian, M; Church, MK; Farré-Albadalejo, M; Giménez-Arnau, A; Krause, K; Martinez-Escala, E; Maurer, M | 1 |
Keam, SJ; Plosker, GL | 1 |
Bachert, C; Bousquet, J; Canonica, WG; Gimenez-Arnau, A; Kowalski, ML; Martí-Guadaño, E; Maurer, M; Mullol, J; Picado, C; Scadding, G; Van Cauwenberge, P | 1 |
Adkinson, NF; Lichtenstein, LM; MacGlashan, DW; Naclerio, R; Peters, SP; Proud, D; Schleimer, RP | 1 |
Czarnetzki, B | 1 |
Archer, CB; Brooks, J; Burton, JL; Sansom, JE | 1 |
Czarnetzki, BM; Hartmann, K; Pfrommer, C; Schwarz, S; Zuberbier, T | 1 |
Armenaka, M; Rosenstreich, DL | 1 |
Juhlin, L; Pihl-Lundin, I | 1 |
Becker, WM; Schade, U; Schaubschläger, WW; Schlaak, M; Zabel, P | 1 |
Juhlin, L; Rihoux, JP | 1 |
Juhlin, L | 1 |
Fukuda, T; Makino, S | 1 |
Eisenstadt, TC; Farr, RS; Grandel, KE; Wanderer, AA; Wasserman, SI | 1 |
Archer, CB | 1 |
Braquet, P; Cournot, A; Duchier, J; Guinot, P | 1 |
Wasserman, SI | 1 |
9 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hives
Article | Year |
---|---|
Rupatadine for the treatment of urticaria.
Topics: Animals; Cyproheptadine; Histamine Antagonists; Humans; Platelet Activating Factor; Urticaria | 2013 |
Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis.
Topics: Conjunctivitis, Allergic; Cyproheptadine; Histamine Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2013 |
Platelet activating factor in allergies.
Topics: Anaphylaxis; Asthma; Eosinophils; Humans; Mast Cells; Platelet Activating Factor; Urticaria | 2015 |
Rupatadine: global safety evaluation in allergic rhinitis and urticaria.
Topics: Animals; Anti-Allergic Agents; Blood-Brain Barrier; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic; Urticaria | 2016 |
Rupatadine for the treatment of allergic rhinitis and urticaria.
Topics: Anti-Allergic Agents; Chronic Disease; Cyproheptadine; Histamine H1 Antagonists; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2011 |
Rupatadine: a review of its use in the management of allergic disorders.
Topics: Adolescent; Adult; Aged; Animals; Anti-Allergic Agents; Cyproheptadine; Drug Interactions; Humans; Hypersensitivity; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Urticaria | 2007 |
Rupatadine in allergic rhinitis and chronic urticaria.
Topics: Adolescent; Animals; Anti-Allergic Agents; Child; Chronic Disease; Clinical Trials as Topic; Cyproheptadine; Dogs; Humans; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal; Treatment Outcome; Urticaria | 2008 |
The pathophysiology of chronic urticaria.
Topics: Chronic Disease; Histamine; Humans; Immunoglobulin E; Kinins; Leukotrienes; Mast Cells; Platelet Activating Factor; Prostaglandins; Urticaria | 1992 |
Mast cell mediators in the blood of patients with asthma.
Topics: Adenosine; Antigens; Asthma; Bronchial Spasm; Chemotactic Factors; Histamine; Humans; Mast Cells; Platelet Activating Factor; Urticaria | 1985 |
3 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hives
Article | Year |
---|---|
Levocetirizine and rupatadine in chronic idiopathic urticaria.
Topics: Adolescent; Adult; Aged; Cetirizine; Child; Chronic Disease; Cyproheptadine; Female; Histamine H1 Antagonists; Histamine H1 Antagonists, Non-Sedating; Humans; Male; Middle Aged; Platelet Activating Factor; Quality of Life; Severity of Illness Index; Tumor Necrosis Factor-alpha; Urticaria; Young Adult | 2015 |
Rupatadine and its effects on symptom control, stimulation time, and temperature thresholds in patients with acquired cold urticaria.
Topics: Adult; Cold Temperature; Cyproheptadine; Double-Blind Method; Environmental Exposure; Female; Histamine Antagonists; Humans; Male; Middle Aged; Platelet Activating Factor; Pruritus; Treatment Outcome; Urticaria | 2010 |
Effects of H1- and H2-antihistamines on platelet-activating factor and bradykinin-induced inflammatory responses in human skin.
Topics: Administration, Oral; Bradykinin; Cimetidine; Codeine; Double-Blind Method; Doxepin; Histamine; Histamine H1 Antagonists; Histamine H2 Antagonists; Humans; Platelet Activating Factor; Skin; Terfenadine; Urticaria | 1996 |
15 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hives
Article | Year |
---|---|
Serum Levels of Vascular Endothelial Growth Factor, Platelet Activating Factor and Eosinophil-Derived Neurotoxin in Chronic Spontaneous Urticaria-A Pilot Study in Adult Patients.
Topics: Adult; Chronic Disease; Chronic Urticaria; Cytokines; Eosinophil-Derived Neurotoxin; Humans; Pilot Projects; Platelet Activating Factor; Pruritus; Urticaria; Vascular Endothelial Growth Factor A | 2022 |
Anti-heat shock protein 10 IgG in chronic spontaneous urticaria: Relation with miRNA-101-5p and platelet-activating factor.
Topics: Autoantibodies; Chronic Disease; Chronic Urticaria; Humans; Immunoglobulin G; Interleukin-4; MicroRNAs; Platelet Activating Factor; Urticaria | 2023 |
Treatment of acquired cold urticaria with rupatadine.
Topics: Adult; Chronic Disease; Cold Temperature; Cyproheptadine; Female; Humans; Middle Aged; Platelet Activating Factor; Treatment Outcome; Urticaria | 2009 |
Platelet-activating factor (PAF) induces wheal and flare skin reactions independent of mast cell degranulation.
Topics: Adult; Cell Degranulation; Codeine; Female; Germany; Histamine; Histamine Release; Humans; Injections, Intradermal; Male; Mast Cells; Microdialysis; Platelet Activating Factor; Reference Values; Sampling Studies; Skin; Skin Tests; Urticaria; Young Adult | 2013 |
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells.
Topics: Basophils; Cell Separation; Cold Temperature; Histamine Release; Humans; Mast Cells; Models, Biological; Physical Exertion; Platelet Activating Factor; Prostaglandin D2; Prostaglandins D; Urticaria | 1984 |
Increased monocyte chemotaxis towards leukotriene B4 and platelet activating factor in patients with inflammatory dermatoses.
Topics: Adolescent; Adult; Cells, Cultured; Chemotaxis, Leukocyte; Child; Dermatitis; Dermatitis, Atopic; Dose-Response Relationship, Immunologic; Female; Humans; Leukotriene B4; Male; Monocytes; Platelet Activating Factor; Psoriasis; Urticaria | 1983 |
Histamine releasability of basophils and skin mast cells in chronic urticaria.
Topics: Adult; Antibodies, Anti-Idiotypic; Basophils; Calcimycin; Cimetidine; Female; Histamine Release; Humans; Immunoglobulin E; Interleukin-3; Leukotriene C4; Male; Mast Cells; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Platelet Activating Factor; Skin; Urticaria | 1996 |
Effects of antihistamines on cutaneous reactions and influx of eosinophils after local injection of PAF, kallikrein, compound 48/80 and histamine in patients with chronic urticaria and healthy subjects.
Topics: Adult; Aged; Chlorpheniramine; Chronic Disease; Eosinophils; Female; Histamine; Histamine H1 Antagonists; Humans; Kallikreins; Loratadine; Male; Middle Aged; p-Methoxy-N-methylphenethylamine; Platelet Activating Factor; Skin; Urticaria | 1992 |
Release of mediators from human gastric mucosa and blood in adverse reactions to benzoate.
Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Aged; Asthma; Benzoates; Benzoic Acid; Dermatitis, Atopic; Endoscopy, Gastrointestinal; Female; Food Additives; Gastric Mucosa; Histamine; Histamine Release; Humans; Male; Middle Aged; Monocytes; Platelet Activating Factor; Urticaria | 1991 |
Effect of cetirizine on cutaneous reactions to PAF, kallikrein and serum in patients with chronic urticaria.
Topics: Adult; Blood Transfusion, Autologous; Cetirizine; Chronic Disease; Female; Histamine; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Urticaria | 1990 |
Late-phase cutaneous reactions to platelet activating factor and kallikrein in urticaria.
Topics: Adult; Cetirizine; Chronic Disease; Female; Histamine H1 Antagonists; Humans; Hydroxyzine; Hypersensitivity, Delayed; Injections, Intradermal; Kallikreins; Male; Middle Aged; Platelet Activating Factor; Skin; Urticaria | 1990 |
[Allergy and PAF].
Topics: Anaphylaxis; Animals; Asthma; Humans; Leukocytes; Macrophages; Mast Cells; Platelet Activating Factor; Rhinitis, Allergic, Perennial; Urticaria | 1991 |
Association of platelet-activating factor with primary acquired cold urticaria.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adult; Angioedema; Biological Assay; Chemotaxis, Leukocyte; Chromatography, Thin Layer; Cold Temperature; Female; Histamine Release; Humans; Male; Phospholipases A; Platelet Activating Factor; Serotonin; Tritium; Urticaria | 1985 |
Mediators of heat urticaria.
Topics: Hot Temperature; Humans; Platelet Activating Factor; Urticaria | 1988 |
Effects of BN 52063 on PAF-acether induced weal and flare in man.
Topics: Adult; Dose-Response Relationship, Drug; Humans; Lactones; Male; Plant Extracts; Platelet Activating Factor; Skin; Urticaria | 1987 |